The impact of CYP2C19 polymorphisms on citalopram metabolism in patients with major depressive disorder

Journal of Clinical Pharmacy and Therapeutics
Z UckunH S Suzen

Abstract

Genetic variations in drug-metabolizing enzyme genes change drug pharmacokinetics and response. CYP2C19 is a clinically important enzyme that metabolizes citalopram (CIT). The objective of this study was to determine CYP2C19 genetic polymorphisms and to evaluate the impact of these polymorphisms on the metabolism of citalopram in a sample of the Turkish population. We also assessed *17 polymorphism in healthy subjects in this population. The CYP2C19 genotypes were determined by polymerase chain reaction-restriction fragment length polymorphism method (209 healthy individuals and 50 patients for CIT metabolism), and the plasma concentrations of CIT and demethylcitalopram (DCIT) were quantified by high-performance liquid chromatography. The CYP2C19*1 and *17 allele frequencies for the patient group and the healthy group were 71·0%, 18·0% and 81·1%, 18·9%, respectively. There was no significant difference between the two groups (P > 0·05). The mean plasma concentrations and the mean dose-corrected (C/D) plasma levels of DCIT were significantly higher in patients with the CYP2C19*1/*1 genotype compared to patients with CYP2C19*1/*2 and CYP2C19*2/*2 genotypes (P < 0·05). Furthermore, the mean metabolic ratio (MR, CIT/DCIT) was also ...Continue Reading

References

Jan 1, 1985·Psychopharmacology·K Fredericson OverøJ P Gylding-Sabroe
Aug 25, 1999·Clinical Pharmacology and Therapeutics·A S AynaciogluJ Brockmöller
Mar 27, 2003·Therapeutic Drug Monitoring·Margareta ReisFinn Bengtsson
Sep 13, 2003·British Journal of Clinical Pharmacology·Karin HerrlinLeif Bertilsson
Sep 17, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Bang-Ning YuHong-Hao Zhou
Aug 26, 2004·British Journal of Clinical Pharmacology·Y S PangChim C Lang
Jul 21, 2006·Journal of Clinical Psychopharmacology·Ophelia Q P YinMoses S S Chow
Aug 17, 2006·European Journal of Clinical Pharmacology·Mateusz KurzawskiMarek Droździk
Jul 13, 2007·Clinical Pharmacology and Therapeutics·I RudbergE Molden
Feb 5, 2008·British Journal of Clinical Pharmacology·Nicole G HunfeldWilliam P Geus
Feb 5, 2008·British Journal of Clinical Pharmacology·Katsuyoshi SugimotoTomonori Tateishi
Feb 26, 2008·British Journal of Clinical Pharmacology·R Michael BaldwinLeif Bertilsson
Jul 26, 2008·European Journal of Clinical Pharmacology·Staffan Ohlsson RosenborgErik Eliasson
May 9, 2009·Molecular Biology Reports·H Sinan SuzenYalcin Duydu
Oct 21, 2009·European Journal of Pharmacology·Salvador FudioJesús Frías
Mar 13, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Gregory L KearnsAndrea Gaedigk
May 26, 2010·European Journal of Clinical Pharmacology·Margareta RamsjöLeif Bertilsson
Nov 3, 2010·European Journal of Clinical Pharmacology·Maud BergeMarie-Anne Loriot
Dec 31, 2010·Pharmacogenetics and Genomics·David A MrazekRichard M Weinshilboum
Mar 26, 2011·Pharmacological Reviews·Qiang Ma, Anthony Y H Lu
Sep 16, 2011·Journal of Clinical Pharmacy and Therapeutics·D AnichavezhiC Adithan
Sep 20, 2011·Journal of Psychopharmacology·Patricia Huezo-DiazKatherine J Aitchison
Sep 21, 2013·International Journal of Medical Sciences·Leena H Saeed, Ahmed Y Mayet
Feb 18, 2014·British Journal of Clinical Pharmacology·Yuan JiRichard M Weinshilboum
Dec 17, 2014·Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences·Maryam PayanReza Tahvilian

❮ Previous
Next ❯

Citations

Feb 3, 2016·International Journal of Clinical Pharmacy·Nazan Yuce-ArtunHalit Sinan Suzen
Apr 18, 2018·Pharmacological Reports : PR·Ádám Ferenc KissKatalin Monostory
Dec 11, 2019·The Pharmacogenomics Journal·Arun RadhakrishnanNikhitha K Shanmukhan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.